Gliclazide, sold under the brand name Diamicron among others, is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. [7] . It is used when dietary changes, exercise, and weight loss are not enough. [4] . It is taken by mouth. [7]

USES: This medication is used in conjunction with diet and exercise regimens to control high blood sugar in non- insulin dependent diabetic patients. Controlling high blood sugar helps prevent heart disease, strokes, kidney disease, circulation problems, and blindness. HOW TO USE: This is best taken with meals.

Gliclazide is a sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus. Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

Jan 7, 2025 · Gliclazide is used for control of blood glucose in patients with non-insulin dependent diabetes mellitus (Type-II, maturity onset diabetes mellitus) whose hyperglycemia cannot be …

Gliclazide is a N-sulfonylurea. It has a role as a hypoglycemic agent, a radical scavenger and an insulin secretagogue. Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

Sep 26, 2022 · Gliclazide works by increasing the amount of insulin that your pancreas produces. It can be given on its own or alongside other antidiabetic medicines or insulin. Some …

Oct 20, 2023 · Gliclazide is an antidiabetic agent belonging to a group of medicines called second-generation sulfonylureas. Gliclazide is approved for managing hyperglycemia in patients with type 2 diabetes. Promoting the pancreas' secretion of insulin and enhancing cells' sensitivity to the hormone helps regulate and lower high blood sugar levels.

Find out how gliclazide treats type 2 diabetes and how to take it. NHS medicines information on gliclazide – what it's used for, side effects, dosage and who can take it.

Gliclazide belongs to the class of medications known as oral hypoglycemics. It is used by people with type 2 diabetes to control blood glucose. It is used when diet, exercise, and weight reduction have not been found to control blood glucose well enough without medication.

Gliclazide MR is proven to offer high efficacy for glucose lowering, low risk of hypoglycemia, weight neutrality, cardiovascular safety, delay of secondary treatment failure, and favorable renal outcomes in patients with chronic kidney disease.